O
OrbiMed’s Exelixis EXEL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-2,404,100
| Closed | -$58.8M | – | 152 |
|
2020
Q3 | $58.8M | Hold |
2,404,100
| – | – | 0.74% | 37 |
|
2020
Q2 | $57.1M | Sell |
2,404,100
-776,000
| -24% | -$18.4M | 0.8% | 37 |
|
2020
Q1 | $54.8M | Sell |
3,180,100
-573,600
| -15% | -$9.88M | 0.92% | 35 |
|
2019
Q4 | $66.1M | Sell |
3,753,700
-159,200
| -4% | -$2.81M | 0.94% | 38 |
|
2019
Q3 | $69.2M | Hold |
3,912,900
| – | – | 1.31% | 26 |
|
2019
Q2 | $83.6M | Buy |
3,912,900
+1,111,000
| +40% | +$23.7M | 1.3% | 23 |
|
2019
Q1 | $66.7M | Hold |
2,801,900
| – | – | 1.03% | 30 |
|
2018
Q4 | $55.1M | Hold |
2,801,900
| – | – | 1.02% | 31 |
|
2018
Q3 | $49.7M | Buy |
2,801,900
+1,120,700
| +67% | +$19.9M | 0.6% | 50 |
|
2018
Q2 | $36.2M | Buy |
+1,681,200
| New | +$36.2M | 0.43% | 63 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 133 |
|
2016
Q4 | – | Sell |
-6,206,300
| Closed | -$79.4M | – | 131 |
|
2016
Q3 | $79.4M | Buy |
+6,206,300
| New | +$79.4M | 0.9% | 44 |
|
2014
Q2 | – | Sell |
-2,888,000
| Closed | -$10.2M | – | 120 |
|
2014
Q1 | $10.2M | Sell |
2,888,000
-6,501,000
| -69% | -$23M | 0.13% | 83 |
|
2013
Q4 | $57.6M | Buy |
9,389,000
+645,000
| +7% | +$3.95M | 0.85% | 37 |
|
2013
Q3 | $50.9M | Buy |
+8,744,000
| New | +$50.9M | 0.91% | 33 |
|